Heart disease and stroke statistics—2022 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association
BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …
2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
[HTML][HTML] Heart disease and stroke statistics-2021 update: a report from the American Heart Association.
Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Evidence-based medical management of peripheral artery disease
GH Bevan, KT White Solaru - Arteriosclerosis, thrombosis, and …, 2020 - Am Heart Assoc
Peripheral artery disease is an atherosclerotic disease of the lower extremities associated
with high cardiovascular mortality. Management of this condition may include lifestyle …
with high cardiovascular mortality. Management of this condition may include lifestyle …
Disparities in anticoagulant therapy initiation for incident atrial fibrillation by race/ethnicity among patients in the veterans health administration system
UR Essien, N Kim, LRM Hausmann, MK Mor… - JAMA network …, 2021 - jamanetwork.com
Importance Atrial fibrillation is a common cardiac rhythm disturbance causing substantial
morbidity and mortality that disproportionately affects racial/ethnic minority groups …
morbidity and mortality that disproportionately affects racial/ethnic minority groups …
Association of race and ethnicity with oral anticoagulation and associated outcomes in patients with atrial fibrillation: findings from the get with the guidelines–atrial …
UR Essien, K Chiswell, LA Kaltenbach… - JAMA …, 2022 - jamanetwork.com
Importance Oral anticoagulation (OAC) is underprescribed in underrepresented racial and
ethnic group individuals with atrial fibrillation (AF). Little is known of how differential OAC …
ethnic group individuals with atrial fibrillation (AF). Little is known of how differential OAC …
Practical “1-2-3-4-day” rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation: combined hospital-based cohort study
S Kimura, K Toyoda, S Yoshimura, K Minematsu… - Stroke, 2022 - Am Heart Assoc
Background: The “1-3-6-12-day rule” for starting direct oral anticoagulants (DOACs) in
patients with nonvalvular atrial fibrillation after acute ischemic stroke or transient ischemic …
patients with nonvalvular atrial fibrillation after acute ischemic stroke or transient ischemic …
Prescribing trends of oral anticoagulants in England over the last decade: a focus on new and old drugs and adverse events reporting
Direct-acting oral anticoagulants (DOACs) are replacing conventional VKA (vitamin K
antagonist, ie, warfarin) for various indications where a therapeutic anticoagulant effect is …
antagonist, ie, warfarin) for various indications where a therapeutic anticoagulant effect is …